This article from the Wall Street Journal ($) reports on a consortium that will shut down a series of cancer clinical trials due to insufficient federal funding. The Coalition of Cancer Cooperative Groups will reduce its trials by some 3,000 patients this year, which will mostly affect studies of less common cancers, according to the article.